Clinical trial
Optimizing Clinical Use of Polymyxin B: Teaching an Old Drug to Treat Superbugs
NCT02682355 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimizing Clinical Use of Polymyxin B: Teaching an Old Drug to Treat Superbugs
- Lead sponsor
- Rutgers, The State University of New Jersey
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- August 3, 2022
- Enrollment
- 155 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
blood stream infection, pneumonia, respiratory tract infection (including tracheobronchitis), sepsis, urinary tract infections